Method for protecting mitochondria in retina cell
US10967019B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2017 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Apr 6, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4875
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A use of an emblica extract in preparing a pharmaceutical composition for protecting mitochondria in retina is provided. When the pharmaceutical composition, which comprises the emblica extract, is provided to retinal cells, a use of the pharmaceutical composition comprises improvement of the ability of performing the oxidative phosphorylation for the synthesis of the adenosine triphosphate (ATP) by the mitochondria in the retinal cells under or exposed to ultraviolet light, and improvement of the coupling efficiency of the synthesis of the adenosine triphosphate by the mitochondria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.